Status:
RECRUITING
No-Stoma Policy in Advanced Ovarian Cancer Surgery
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Ovary Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Resection of the sigmoid-rectum is a procedure frequently required in cytoreductive surgery for advanced ovarian cancer, and it is also among the procedures with the highest risk of complications. One...
Eligibility Criteria
Inclusion
- Patients with suspected or anatomopathological diagnosis of malignant ovarian tumor undergoing elective primary or secondary cytoreduction and needing rectosigmoid resection and anastomosis
- Informed consent signed prior to performing any procedure related to the clinical trial
- Age 18 years old.
Exclusion
- Patients with histologies other than ovarian tumor.
- Only palliative surgery planned
- Patients who do not require sigmoid-rectum resection after intraoperative evaluation
- Patients who do not receive colorectal anastomosis and undergo end ostomy
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2028
Estimated Enrollment :
395 Patients enrolled
Trial Details
Trial ID
NCT07213193
Start Date
May 1 2025
End Date
December 20 2028
Last Update
October 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Ginecologia Oncologica
Roma, Italy, 00168